Flerie
Flerie Invest Ab is a venture capital firm founded in 2011 and based in Stockholm, Sweden, with an additional office in London, United Kingdom. The firm specializes in early-stage and growth-stage investments, primarily focusing on companies involved in drug development and related tools or applications that address significant medical challenges. Flerie Invest aims to support innovative healthcare ventures across Europe, the United States, the United Kingdom, and Israel, contributing to advancements in the healthcare sector.
Past deals in Infants
Vitara Biomedical
Series B in 2024
Vitara Biomedical is focused on developing a therapeutic platform designed to support premature infants. The company draws inspiration from natural physiological processes to improve neonatal care, aiming to enhance the quality of life for these vulnerable newborns. By addressing the unique challenges faced by premature infants, Vitara Biomedical seeks to reduce mortality rates and associated health complications, ultimately providing a foundation for a healthier future for both infants and their families.
Vitara Biomedical
Series B in 2022
Vitara Biomedical is focused on developing a therapeutic platform designed to support premature infants. The company draws inspiration from natural physiological processes to improve neonatal care, aiming to enhance the quality of life for these vulnerable newborns. By addressing the unique challenges faced by premature infants, Vitara Biomedical seeks to reduce mortality rates and associated health complications, ultimately providing a foundation for a healthier future for both infants and their families.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.